BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20625145)

  • 1. Efficacy of PTX3 in a rat model of invasive aspergillosis.
    Lo Giudice P; Campo S; Verdoliva A; Rivieccio V; Borsini F; De Santis R; Salvatori G
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4513-5. PubMed ID: 20625145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PTX3 and voriconazole combination in a rat model of invasive pulmonary aspergillosis.
    Lo Giudice P; Campo S; De Santis R; Salvatori G
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6400-2. PubMed ID: 23006752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response.
    Garlanda C; Hirsch E; Bozza S; Salustri A; De Acetis M; Nota R; Maccagno A; Riva F; Bottazzi B; Peri G; Doni A; Vago L; Botto M; De Santis R; Carminati P; Siracusa G; Altruda F; Vecchi A; Romani L; Mantovani A
    Nature; 2002 Nov; 420(6912):182-6. PubMed ID: 12432394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current understanding of PTX3 protective activity on Aspergillus fumigatus infection.
    Salvatori G; Campo S
    Med Mycol; 2012 Apr; 50(3):225-33. PubMed ID: 22309253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of PTX3 and posaconazole combination in a rat model of invasive pulmonary aspergillosis.
    Marra E; Sousa VL; Gaziano R; Pacello ML; Arseni B; Aurisicchio L; De Santis R; Salvatori G
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6284-6. PubMed ID: 25070103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentraxin 3 levels in bronchoalveolar lavage fluid of lung transplant recipients with invasive aspergillosis.
    Kabbani D; Bhaskaran A; Singer LG; Bhimji A; Rotstein C; Keshavjee S; Liles WC; Husain S
    J Heart Lung Transplant; 2017 Sep; 36(9):973-979. PubMed ID: 28487045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Aspergillus fumigatus efficacy of pentraxin 3 alone and in combination with antifungals.
    Gaziano R; Bozza S; Bellocchio S; Perruccio K; Montagnoli C; Pitzurra L; Salvatori G; De Santis R; Carminati P; Mantovani A; Romani L
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4414-21. PubMed ID: 15504871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exogenous pentraxin 3 restores antifungal resistance and restrains inflammation in murine chronic granulomatous disease.
    D'Angelo C; De Luca A; Zelante T; Bonifazi P; Moretti S; Giovannini G; Iannitti RG; Zagarella S; Bozza S; Campo S; Salvatori G; Romani L
    J Immunol; 2009 Oct; 183(7):4609-18. PubMed ID: 19734205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCAAT/enhancer binding protein (C/EBP) delta promotes the expression of PTX3 and macrophage phagocytosis during A. fumigatus infection.
    Liu L; Zhong J; Chen B; Wang W; Xi H; Su X
    J Leukoc Biol; 2022 Jun; 111(6):1225-1234. PubMed ID: 34939225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.
    Lewis RE; Prince RA; Chi J; Kontoyiannis DP
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3208-14. PubMed ID: 12234846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentraxin 3 in bronchoalveolar lavage fluid and plasma in non-neutropenic patients with pulmonary aspergillosis.
    Li H; Liu L; Zhou W; Rui Y; He B; Shi Y; Su X
    Clin Microbiol Infect; 2019 Apr; 25(4):504-510. PubMed ID: 29964232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTX3 binds MD-2 and promotes TRIF-dependent immune protection in aspergillosis.
    Bozza S; Campo S; Arseni B; Inforzato A; Ragnar L; Bottazzi B; Mantovani A; Moretti S; Oikonomous V; De Santis R; Carvalho A; Salvatori G; Romani L
    J Immunol; 2014 Sep; 193(5):2340-8. PubMed ID: 25049357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.
    van de Sande WW; van Vianen W; ten Kate MT; Vissers J; Laurijsens J; Tavakol M; Rijnders BJ; Mathot RA; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1345-50. PubMed ID: 18195059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentraxin 3 Gene Polymorphisms and Pulmonary Aspergillosis in Chronic Obstructive Pulmonary Disease Patients.
    He Q; Li H; Rui Y; Liu L; He B; Shi Y; Su X
    Clin Infect Dis; 2018 Jan; 66(2):261-267. PubMed ID: 29020397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation.
    Cunha C; Aversa F; Lacerda JF; Busca A; Kurzai O; Grube M; Löffler J; Maertens JA; Bell AS; Inforzato A; Barbati E; Almeida B; Santos e Sousa P; Barbui A; Potenza L; Caira M; Rodrigues F; Salvatori G; Pagano L; Luppi M; Mantovani A; Velardi A; Romani L; Carvalho A
    N Engl J Med; 2014 Jan; 370(5):421-32. PubMed ID: 24476432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
    van Vianen W; de Marie S; ten Kate MT; Mathot RA; Bakker-Woudenberg IA
    J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complement system in Aspergillus fumigatus infections and its crosstalk with pentraxins.
    Parente R; Doni A; Bottazzi B; Garlanda C; Inforzato A
    FEBS Lett; 2020 Aug; 594(16):2480-2501. PubMed ID: 31994174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis.
    Kurtz MB; Bernard EM; Edwards FF; Marrinan JA; Dropinski J; Douglas CM; Armstrong D
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1784-9. PubMed ID: 7486919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of SCH 39304 in treatment of experimental invasive aspergillosis.
    Patterson TF; George D; Ingersoll R; Miniter P; Andriole VT
    Antimicrob Agents Chemother; 1991 Oct; 35(10):1985-8. PubMed ID: 1759818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTX3 as a potential novel tool for the diagnosis and monitoring of pulmonary fungal infections in immuno-compromised pediatric patients.
    Biagi E; Col M; Migliavacca M; Dell'Oro M; Silvestri D; Montanelli A; Peri G; Mantovani A; Biondi A; Rossi MR
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):881-5. PubMed ID: 19131771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.